Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioAge Labs, Inc. - Common Stock (NQ: BIOA )

4.700 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 233
Open 4.700
Bid (Size) 4.700 (2)
Ask (Size) 5.310 (4)
Prev. Close 4.700
Today's Range 4.700 - 4.700
52wk Range 3.850 - 26.62
Shares Outstanding 129,450,655
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BIOA Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against BioAge Labs, Inc.
From Robbins LLP
Via GlobeNewswire
Law Offices of Frank R. Cruz Encourages BioAge Labs, Inc. (BIOA) Investors to Inquire About Securities Fraud Class Action
From Law Offices of Frank R. Cruz
Via Business Wire

Performance

YTD
-15.47%
-15.47%
1 Month
+13.53%
+13.53%
3 Month
-80.51%
-80.51%
6 Month
-74.33%
-74.33%
1 Year
-74.33%
-74.33%

More News

Read More
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages BioAge Labs, Inc. (BIOA) Investors To Inquire About Securities Fraud Class Action
From Glancy Prongay & Murray LLP
Via Business Wire
BIOA INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against BioAge Labs, Inc. (NASDAQ: BIOA); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
From DiCello Levitt LLP
Via GlobeNewswire
Law Offices of Howard G. Smith Encourages BioAge Labs, Inc. (BIOA) Investors To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
BIOA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
BioAge Labs, Inc. (BIOA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Securities Fraud Investigation Into BioAge Labs, Inc. (BIOA) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Securities Fraud Investigation Into BioAge Labs, Inc. (BIOA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
Stockholder Notice: Robbins LLP Informs Stockholders of the BioAge Labs, Inc. Class Action
From Robbins LLP
Via GlobeNewswire
Rosen Law Firm Urges BioAge Labs, Inc. (NASDAQ: BIOA) Stockholders to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
BIOAGE LABS, INC. (NASDAQ: BIOA) INVESTOR ALERT: Investors With Large Losses in BioAge Labs, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
BIOAGE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against BioAge Labs, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
From Faruqi & Faruqi LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Franklin, MediaAlpha, e.l.f. Beauty, and BioAge and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of BioAge Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions
From BioAge Labs, Inc.
Via GlobeNewswire
BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of BioAge Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
BioAge Labs, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by BioAge Labs, Inc. (BIOA)
Via ACCESSWIRE
Levi & Korsinsky Announces an Investigation on Behalf of BioAge Labs, Inc. (BIOA) Shareholders Who May Have Been Affected by Fraud
Via ACCESSWIRE
ATTENTION BIOA SHAREHOLDERS: Investors who lost money on BioAge Labs, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
Via ACCESSWIRE
BioAge Labs, Inc. Being Investigated on Behalf of BioAge Labs, Inc. Investors. Contact Levi & Korsinsky For Details
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.